-
EP3313878
European procedure
Extract from the Register of European Patents
EP Citations: EP3313878
| Cited in | International search | Type: | Patent literature | Publication No.: | WO2008044068
[A] (FUSION ANTIBODIES LTD [GB], et al) [A] 33-72 * page 77, lines 22-26; figures 17-32 *; | Type: | Non-patent literature | Publication information: | [XI] - S. A. PRADHAN ET AL, "Evidence that TSC2 acts as a transcription factor and binds to and represses the promoter of Epiregulin", NUCLEIC ACIDS RESEARCH, GB, (20140602), vol. 42, no. 10, doi:10.1093/nar/gku278, ISSN 0305-1048, pages 6243 - 6255, XP055297266 [X] 1,27-32,52-69 * page 6244, column r, line 1; figure 5A * [I] 2-13,70-72 | DOI: | http://dx.doi.org/10.1093/nar/gku278 | Type: | Non-patent literature | Publication information: | [ ] - Abcam, "Anti-EREG antibody -C-terminal", (20140206), URL: http://www.abcam.com/EREG-antibody-C-terminal-ab175118.pdf, (20160824), XP055297270 [ ] * the whole document * | Type: | Non-patent literature | Publication information: | [XI] - Cell Signaling Technology, "EREG (D4O5I) Rabbit mAb", (20140917), URL: http://media.cellsignal.com/pdf/12048.pdf, (20160823), XP055297126 [X] 1,27-32,52-69 * the whole document * [I] 2-13,70-72 | Type: | Non-patent literature | Publication information: | [I] - J. ZHANG ET AL, "Intratumoral Epiregulin Is a Marker of Advanced Disease in Non-Small Cell Lung Cancer Patients and Confers Invasive Properties on EGFR-Mutant Cells", CANCER PREVENTION RESEARCH, United States, (20080518), vol. 1, no. 3, doi:10.1158/1940-6207.CAPR-08-0014, ISSN 1940-6207, pages 201 - 207, XP055297042 [I] 1-13,27-32,52-72 * figure 1 * | DOI: | http://dx.doi.org/10.1158/1940-6207.CAPR-08-0014 | Type: | Non-patent literature | Publication information: | [XI] - AHLBORG N ET AL, "Generation of antibodies to human IL-12 and amphiregulin by immunization of Balb/c mice with diepitope multiple antigen peptides - I. Determination of the selectivity of six antibodies by cell-ELISA and immunofluorescence", JOURNAL OF IMMUNOLOGICAL METHODS, ELSEVIER SCIENCE PUBLISHERS B.V.,AMSTERDAM, NL, (19970512), vol. 204, no. 1, doi:10.1016/S0022-1759(97)00035-5, ISSN 0022-1759, pages 23 - 32, XP004107713 [X] 33,46 * figures 1-4; table 1 * [I] 34-45,47-72 | DOI: | http://dx.doi.org/10.1016/S0022-1759(97)00035-5 | Type: | Non-patent literature | Publication information: | [XI] - M. ISOKANE ET AL, "Plasma-membrane-anchored growth factor pro-amphiregulin binds A-type lamin and regulates global transcription", JOURNAL OF CELL SCIENCE, GB, (20081101), vol. 121, no. 21, doi:10.1242/jcs.031443, ISSN 0021-9533, pages 3608 - 3618, XP055306354 [X] 33,46-69 * page 3617, column l, paragraphs 1-3; figures 1-8 * [I] 34-45,70-72 | DOI: | http://dx.doi.org/10.1242/jcs.031443 | Type: | Non-patent literature | Publication information: | [A] - D J JONKER ET AL, "Epiregulin gene expression as a biomarker of benefit from cetuximab in the treatment of advanced colorectal cancer", BRITISH JOURNAL OF CANCER, GB, (20131212), vol. 110, no. 3, doi:10.1038/bjc.2013.753, ISSN 0007-0920, pages 648 - 655, XP055297354 [A] 1-13,27-32,52-72 * figures 1-3; tables 1,2 * | DOI: | http://dx.doi.org/10.1038/bjc.2013.753 | Type: | Non-patent literature | Publication information: | [A] - FUSANORI YOTSUMOTO ET AL, "Amphiregulin regulates the activation of ERK and Akt through epidermal growth factor receptor and HER3 signals involved in the progression of pancreatic cancer", CANCER SCIENCE, JP, (20100707), vol. 101, no. 11, doi:10.1111/j.1349-7006.2010.01671.x, ISSN 1347-9032, pages 2351 - 2360, XP055226799 [A] 33-72 * the whole document * | DOI: | http://dx.doi.org/10.1111/j.1349-7006.2010.01671.x | Type: | Non-patent literature | Publication information: | [A] - N. ECKSTEIN ET AL, "Epidermal Growth Factor Receptor Pathway Analysis Identifies Amphiregulin as a Key Factor for Cisplatin Resistance of Human Breast Cancer Cells", JOURNAL OF BIOLOGICAL CHEMISTRY, US, (20080111), vol. 283, no. 2, doi:10.1074/jbc.M706287200, ISSN 0021-9258, pages 739 - 750, XP055280410 [A] 33-72 * the whole document * | DOI: | http://dx.doi.org/10.1074/jbc.M706287200 |